Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MongoDB A | MDB | Nov 25, 2024 | 341.36 | +2.66 |
Monogram Technologies | MGRM | Nov 25, 2024 | 2.08 | +5.58 |
Monolithic Power Systems | MPWR | Nov 25, 2024 | 600.86 | +3.45 |
Monopar Therapeutics | MNPR | Nov 25, 2024 | 19.40 | -3.48 |
Monro | MNRO | Nov 25, 2024 | 28.27 | +4.55 |
Monroe Capital | MRCC | Nov 25, 2024 | 8.49 | +0.95 |
Monster Beverage | MNST | Nov 25, 2024 | 54.98 | +1.70 |
Montauk Renewables | MNTK | Nov 25, 2024 | 4.49 | +0.67 |
Monte Rosa Therapeutics | GLUE | Nov 25, 2024 | 8.46 | -0.35 |
Montrose Environmental Group | MEG | Nov 25, 2024 | 19.25 | +7.60 |
Moodys | MCO | Nov 25, 2024 | 494.03 | +2.78 |
Moog A | MOG-A | Nov 25, 2024 | 224.02 | +0.66 |
Moog B | MOG-B | Nov 25, 2024 | 214.95 | 0.00 |
Moolec Science | MLEC | Nov 25, 2024 | 0.89 | 0.00 |
MoonLake Immunotherapeutics | MLTX | Nov 25, 2024 | 54.17 | -0.28 |
Morgan Stanley | MS | Nov 25, 2024 | 133.66 | -0.76 |
Morgan Stanley China A Share Fund | CAF | Nov 25, 2024 | 12.33 | +0.08 |
Morgan Stanley Direct Lending Fund | MSDL | Nov 25, 2024 | 20.80 | +1.81 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Nov 25, 2024 | 7.75 | +0.65 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Nov 25, 2024 | 4.68 | +1.52 |
Morgan Stanley FXDFR Pref | MS-K | Nov 25, 2024 | 25.18 | +0.08 |
Morgan Stanley India Investment Fund | IIF | Nov 25, 2024 | 28.37 | +1.68 |
Morgan Stanley Pref A | MS-A | Nov 25, 2024 | 23.68 | +0.21 |
Morgan Stanley Pref E | MS-E | Nov 25, 2024 | 25.35 | +0.04 |
Morgan Stanley Pref F | MS-F | Nov 25, 2024 | 25.31 | -0.04 |
Morgan Stanley Pref I | MS-I | Nov 25, 2024 | 25.39 | -0.01 |
Morgan Stanley Pref L | MS-L | Nov 25, 2024 | 22.92 | +0.39 |
Morgan Stanley Pref O | MS-O | Nov 25, 2024 | 19.41 | +1.20 |
Morgan Stanley Pref P | MS-P | Nov 25, 2024 | 26.38 | +0.57 |
Morgan Stanley Pref Q | MS-Q | Nov 25, 2024 | 26.59 | +0.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.